✦ LIBER ✦

Taspoglutide, a once-weekly glucagon-like peptide 1 analogue, vs. insulin glargine titrated to target in patients with Type 2 diabetes: an open-label randomized trial

✍ Scribed by Nauck, M.; Horton, E.; Andjelkovic, M.; Ampudia-Blasco, F. J.; Parusel, C. T.; Boldrin, M.; Balena, R.

Book ID: 119827892
Publisher: John Wiley and Sons
Year: 2012
Tongue: English
Weight: 162 KB
Volume: 30
Category: Article
ISSN: 0742-3071
DOI: 10.1111/dme.12003

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Once weekly exenatide compared with insu

Once weekly exenatide compared with insulin glargine titrated to target in patients with type 2 diabetes (DURATION-3): an open-label randomised trial

✍ Michaela Diamant; Luc Van Gaal; Stephen Stranks; Justin Northrup; Dachuang Cao; 📂 Article 📅 2010 🏛 The Lancet 🌐 English ⚖ 496 KB

Comparison of insulin detemir and insuli

Comparison of insulin detemir and insulin glargine in a basal—bolus regimen, with insulin aspart as the mealtime insulin, in patients with type 1 diabetes: A 52-week, multinational, randomized, open-label, parallel-group, Treat-to-Target noninferiority trial

✍ Simon Heller; Christoph Koenen; Bruce Bode 📂 Article 📅 2009 🏛 Elsevier Science 🌐 English ⚖ 237 KB

Efficacy and safety of insulin degludec

Efficacy and safety of insulin degludec three times a week versus insulin glargine once a day in insulin-naive patients with type 2 diabetes: results of two phase 3, 26 week, randomised, open-label, treat-to-target, non-inferiority trials

✍ Zinman, Bernard; DeVries, J Hans; Bode, Bruce; Russell-Jones, David; Leiter, Law 📂 Article 📅 2013 🏛 Elsevier 🌐 English ⚖ 337 KB

The Efficacy and Safety of Insulin Deglu

The Efficacy and Safety of Insulin Degludec Given in Variable Once-Daily Dosing Intervals Compared With Insulin Glargine and Insulin Degludec Dosed at the Same Time Daily: A 26-week, randomized, open-label, parallel-group, treat-to-target trial in individuals with type 2 diabetes

✍ Meneghini, L.; Atkin, S. L.; Gough, S. C. L.; Raz, I.; Blonde, L.; Shestakova, M 📂 Article 📅 2013 🏛 American Diabetes Association 🌐 English ⚖ 842 KB